Seeded with a $2.5 million grant from the Nevada Governor’s Office of Economic Development and matching funds from UNLV, the institute will decode people’s genomes to predict individual susceptibility to disease, study treatment options and fine-tune drug dosages to minimize adverse effects, Executive Director Martin Schiller said.

Unseasonably warm temperatures over the past month have brought an early start to the allergy season.